Early Screening and Treatment of Heart Complication in Sickle Cell Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07023666
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07023666
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07023666. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-07 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Screening and Treatment of Heart Complication in Sickle Cell Disease
- Condition
- Sickle Cell Disease
- Intervention (Drug)
- Deferoxamine
- Intervention (Drug)
- Deferasirox
- Intervention (Drug)
- Deferiprone
- Intervention (Device)
- Echocardiography
- Intervention (Device)
- Electrocardiogram (ECG (electrocardiogram))
- Lead sponsor
- Inova Health Care Services
Record details
- Record id
cardio:ct-nct07023666- Content hash
5cf4a9cf813ab559cebeb7120b12f19bd6bd1b27be404ed07272b075e934d409